The Spleen Tyrosine Kinase (SYK): A Crucial Therapeutic Target for Diverse Liver Diseases

The blockage of spleen tyrosine kinase (SYK) activity using small molecule modulators is considered as a significant therapeutic strategy against liver diseases, and both hepatic SYK and non-hepatic SYK could become highly promising therapeutic targets.